Los Angeles Capital Management’s Abiomed Inc ABMD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
Sell
-2,104
Closed -$517K 1308
2022
Q3
$517K Buy
+2,104
New +$568K ﹤0.01% 921
2022
Q1
Sell
-1,605
Closed -$576K 1526
2021
Q4
$576K Sell
1,605
-40,324
-96% -$13.6M ﹤0.01% 938
2021
Q3
$13.6M Buy
41,929
+8,126
+24% +$2.75M 0.06% 237
2021
Q2
$10.6M Sell
33,803
-1,594
-5% -$489K 0.05% 289
2021
Q1
$11.3M Sell
35,397
-44,120
-55% -$14.1M 0.05% 289
2020
Q4
$25.8M Buy
79,517
+30,720
+63% +$8.5M 0.11% 169
2020
Q3
$13.5M Buy
48,797
+21,417
+78% +$6.17M 0.06% 215
2020
Q2
$6.61M Buy
27,380
+14,327
+110% +$2.88M 0.03% 345
2020
Q1
$1.9M Sell
13,053
-1,056
-7% -$175K 0.01% 547
2019
Q4
$2.41M Sell
14,109
-97
-0.7% -$18K 0.01% 597
2019
Q3
$2.53M Sell
14,206
-72,196
-84% -$15.6M 0.01% 563
2019
Q2
$22.5M Buy
86,402
+51,720
+149% +$13.7M 0.12% 194
2019
Q1
$9.9M Buy
34,682
+11,970
+53% +$3.98M 0.06% 306
2018
Q4
$7.38M Buy
22,712
+7,786
+52% +$2.7M 0.05% 316
2018
Q3
$6.71M Sell
14,926
-1,894
-11% -$747K 0.04% 407
2018
Q2
$6.88M Buy
16,820
+12,510
+290% +$4.53M 0.04% 426
2018
Q1
$1.25M Buy
+4,310
New +$1.09M 0.01% 761
2017
Q4
Sell
-8,533
Closed -$1.44M 1415
2017
Q3
$1.44M Sell
8,533
-14,433
-63% -$2.18M 0.01% 709
2017
Q2
$3.29M Buy
22,966
+21,017
+1,078% +$2.82M 0.02% 511
2017
Q1
$244K Buy
+1,949
New +$226K ﹤0.01% 1051
2016
Q1
Sell
-2,470
Closed -$223K 1213
2015
Q4
$223K Buy
2,470
+40
+2% +$3.4K ﹤0.01% 1044
2015
Q3
$225K Buy
+2,430
New +$214K ﹤0.01% 1081

Other funds holding ABMD

Los Angeles Capital Management's ABMD Position: Q4 2022 in Review

Los Angeles Capital Management sold out of Abiomed Inc (ABMD) in Q4 2022, closing a stake of 2,104 shares — an estimated $517K sold.

Los Angeles Capital Management first reported a position in ABMD in Q3 2015 and held it in 22 quarters. The position peaked at $25.8M in Q4 2020. 8 funds tracked by Wall St. Rank hold ABMD as of Q4 2022.

  • Los Angeles Capital Management reported no remaining Abiomed Inc position as of Q4 2022 after selling out during the quarter.
  • Los Angeles Capital Management sold 2,104 Abiomed Inc shares in Q4 2022, an estimated $517K.
  • Los Angeles Capital Management first reported a position in Abiomed Inc in Q3 2015 and held it in 22 quarters.
  • Los Angeles Capital Management's Abiomed Inc position peaked at $25.8M in Q4 2020.
  • 8 funds tracked by Wall St. Rank held Abiomed Inc as of Q4 2022.

Based on Los Angeles Capital Management's 13F filing for Q4 2022, filed 6 Feb 2023.